MoneyWorks4Me

With no major difference for the quarter endedSeptember 2022 , the total revenue stood at Rs. 358.52  millions.The Net proft of the company remain more or less same to Rs. 68.67  millions from Rs. 79.70 millions ,decline by -13.84%.Operating profit for the quarter ended September 2022 decreased to 98.78 millions as compared to 114.59 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 358.52 355.08 0.97 669.84 626.88 6.85 1239.80 1092.94 13.44
Other Income 12.61 11.91 5.88 24.04 23.86 0.75 49.49 43.08 14.88
PBIDT 98.78 114.59 -13.80 182.93 180.14 1.55 322.04 241.52 33.34
Interest 0.93 1.09 -14.68 1.80 2.12 -15.09 4.35 4.74 -8.23
PBDT 97.85 113.50 -13.79 181.13 178.02 1.75 317.69 236.78 34.17
Depreciation 5.45 4.54 20.04 10.80 8.88 21.62 18.99 20.35 -6.68
PBT 92.40 108.96 -15.20 170.33 169.14 0.70 298.70 216.43 38.01
TAX 23.73 29.26 -18.90 42.13 42.93 -1.86 75.74 51.39 47.38
Deferred Tax -1.27 -0.74 71.62 -2.10 -1.35 55.56 2.96 -3.91 -175.70
PAT 68.67 79.70 -13.84 128.20 126.21 1.58 222.96 165.04 35.09
Equity 45.89 45.89 0.00 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 27.55 32.27 -14.62 27.31 28.74 -4.96 25.98 22.10 17.54
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..